MustGrow Biologics Corp. (TSXV:MGRO)

Market Cap	37.67M
Revenue (ttm)	7.03M
Net Income (ttm)	-5.62M
Shares Out	58.85M
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,150
Average Volume	18,321
Open	0.6400
Previous Close	0.6400
Day's Range	0.6400 - 0.6500
52-Week Range	0.5100 - 2.5300
Beta	2.19
RSI	32.99
Earnings Date	Aug 26, 2025

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: MGRO

Financial Performance

In 2024, MustGrow Biologics's revenue was 398,018, a decrease of -91.55% compared to the previous year's 4.71 million. Losses were -4.89 million, 622.2% more than in 2023.